Drs. Park and Wilber have dedicated their careers to creating therapies that are not only effective but also accessible ...
Local groups are raising awareness about sickle cell disease and encouraging people to roll up their sleeves and donate blood. Sickle cell disease is a genetic blood disorder ...
“It can hit you out of nowhere,” she tells TODAY.com.
As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most ...
A Kansas City mother is being honored during Black History Month for turning her family’s personal struggle into a mission ...
Fulcrum Therapeutics, Inc. ( FULC) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST Good morning, and welcome to the Fulcrum Therapeutics conference call to discuss 12-week data from the ...
Fulcrum Therapeutics reports promising Phase 1b data for pociredir in sickle cell disease and a strong cash position to fund development into 2029, boosting investor confidence.
Blood Assurance reported that its blood supply is critically low and urgently needs donors, especially Black donors, to help ...
CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...
Fulcrum's new sickle cell trial data show higher hemoglobin levels and no serious safety concerns in sickle cell disease ...
New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results